Search Results for "Alnylam"
Alnylam is committed to providing the healthcare community with balanced, accurate, and high-quality information about our science, therapeutic areas, and products.
More than one search term is recommended to yield the most relevant results. By searching, you confirm that your query is unsolicited.
For more information about our FDA-approved therapies, please see the Full Prescribing Information:
Vutrisiran: Arthralgia
Standard response letter on vutrisiran and the adverse event of arthralgia.
Standard response letter on vutrisiran and the adverse event of arthralgia.
Patisiran: Orthostatic Hypotension
Standard response letter on the effect of patisiran on orthostatic hypotension in the APOLLO, Global OLE, and HELIOS-A studies.
Standard response letter on the effect of patisiran on orthostatic hypotension in the APOLLO, Global OLE, and HELIOS-A studies.
Vutrisiran: HELIOS-B
Standard response letter on vutrisiran and the HELIOS-B study, a phase 3 study evaluating the efficacy and safety of vutrisiran in patients with the cardiomyopathy of ATTR, including both hATTR and wtATTR.
Standard response letter on vutrisiran and the HELIOS-B study, a phase 3 study evaluating the efficacy and safety of vutrisiran in patients with the cardiomyopathy of ATTR, including both hATTR and wtATTR.
Vutrisiran: Drug Interactions
Standard response letter on vutrisiran and drug interactions.
Standard response letter on vutrisiran and drug interactions.
Vutrisiran: Dosage & Administration Schedule Used in Phase 3 Studies
Standard response letter on the dosing schedules of vutrisiran used in the HELIOS-A and HELIOS-B studies.
Standard response letter on the dosing schedules of vutrisiran used in the HELIOS-A and HELIOS-B studies.
Zilebesiran: Phase 2 Studies
Standard response letter on zilebesiran and the phase 2 studies: KARDIA-1, KARDIA-2, and KARDIA-3.
Standard response letter on zilebesiran and the phase 2 studies: KARDIA-1, KARDIA-2, and KARDIA-3.
Patisiran: Patients with Heart Transplant
Standard response letter on patisiran and use in patients with heart transplant.
Standard response letter on patisiran and use in patients with heart transplant.